TECTONIC THERAPEUTIC, INC. Operating Income
TECTONIC THERAPEUTIC, INC. (TECX) reported Operating Income of -$24.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. operating income (loss) for the quarter ending 2026-06-30 was -$24.22M.
- TECTONIC THERAPEUTIC, INC. operating income (loss) for the quarter ending 2026-03-31 was -$27.30M.
- TECTONIC THERAPEUTIC, INC. operating income (loss) for the quarter ending 2025-12-31 was -$21.52M.
- TECTONIC THERAPEUTIC, INC. operating income (loss) for the quarter ending 2025-09-30 was -$21.89M.
- TECTONIC THERAPEUTIC, INC. operating income (loss) for fiscal 2025 was -$84.04M.
- TECTONIC THERAPEUTIC, INC. operating income (loss) for fiscal 2024 was -$58.02M.
- TECTONIC THERAPEUTIC, INC. operating income (loss) for fiscal 2023 was -$44.65M.
- TECTONIC THERAPEUTIC, INC. operating income (loss) for fiscal 2022 was -$105.43M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$24.22M 10-Q · filed 2026-08-06 | -$51.52M 10-Q · filed 2026-08-06 | -$73.03M derived: sum of 3 quarters · filed 2026-08-06 | -$94.92M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$27.30M 10-Q · filed 2026-05-07 | -$48.82M derived: sum of 2 quarters · filed 2026-05-07 | -$70.71M derived: sum of 3 quarters · filed 2026-05-07 | -$93.04M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$21.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$43.41M derived: sum of 2 quarters · filed 2026-02-26 | -$65.74M derived: sum of 3 quarters · filed 2026-08-06 | -$84.04M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$21.89M 10-Q · filed 2025-11-06 | -$44.22M derived: sum of 2 quarters · filed 2026-08-06 | -$62.52M 10-Q · filed 2025-11-06 | -$76.51M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$22.33M 10-Q · filed 2026-08-06 | -$40.63M 10-Q · filed 2026-08-06 | -$54.62M derived: sum of 3 quarters · filed 2026-08-06 | -$74.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$18.30M 10-Q · filed 2026-05-07 | -$32.29M derived: sum of 2 quarters · filed 2026-05-07 | -$51.93M derived: sum of 3 quarters · filed 2026-05-07 | -$63.35M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$13.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$33.63M derived: sum of 2 quarters · filed 2026-02-26 | -$45.05M derived: sum of 3 quarters · filed 2026-02-26 | -$58.02M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$19.64M 10-Q · filed 2025-11-06 | -$31.06M derived: sum of 2 quarters · filed 2025-11-06 | -$44.02M 10-Q · filed 2025-11-06 | -$53.40M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$11.42M 10-Q · filed 2025-08-07 | -$24.39M 10-Q · filed 2025-08-07 | -$33.76M derived: sum of 3 quarters · filed 2025-08-07 | -$43.88M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$12.97M 10-Q · filed 2025-05-08 | -$7.94M 10-Q · filed 2024-05-09 | -$22.34M derived: sum of 2 quarters · filed 2025-05-08 | -$32.46M derived: sum of 3 quarters · filed 2025-05-08 | -$43.09M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$9.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$19.49M derived: sum of 2 quarters · filed 2025-03-20 | -$30.12M derived: sum of 3 quarters · filed 2025-03-20 | -$44.65M 10-K · filed 2025-03-20 | $10.19M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | -$10.11M 10-Q · filed 2024-11-12 | -$22.93M 10-Q · filed 2023-11-09 | -$20.75M derived: sum of 2 quarters · filed 2024-11-12 | -$35.27M 10-Q · filed 2024-11-12 | $19.85M 10-Q · filed 2023-11-09 | -$71.22M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$10.63M 10-Q · filed 2024-08-14 | $68.01M 10-Q · filed 2023-08-10 | -$25.16M 10-Q · filed 2024-08-14 | $42.79M 10-Q · filed 2023-08-10 | -$61.11M derived: sum of 3 quarters · filed 2024-08-14 | -$84.09M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$25.22M 10-Q · filed 2024-05-09 | -$50.48M derived: sum of 2 quarters · filed 2024-05-09 | -$73.46M derived: sum of 3 quarters · filed 2024-05-09 | -$101.24M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$25.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$48.24M derived: sum of 2 quarters · filed 2024-03-14 | -$76.02M derived: sum of 3 quarters · filed 2024-03-14 | -$105.43M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$22.98M 10-Q · filed 2023-11-09 | -$50.76M derived: sum of 2 quarters · filed 2023-11-09 | -$80.18M 10-Q · filed 2023-11-09 | -$108.14M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$27.77M 10-Q · filed 2023-08-10 | -$57.19M 10-Q · filed 2023-08-10 | -$85.15M derived: sum of 3 quarters · filed 2023-08-10 | -$117.77M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$29.42M 10-Q · filed 2023-05-11 | -$57.38M derived: sum of 2 quarters · filed 2023-05-11 | -$90.00M derived: sum of 3 quarters · filed 2023-05-11 | -$121.38M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$27.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$60.58M derived: sum of 2 quarters · filed 2023-03-23 | -$91.96M derived: sum of 3 quarters · filed 2023-03-23 | -$118.84M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$32.62M 10-Q · filed 2022-11-08 | -$63.99M derived: sum of 2 quarters · filed 2022-11-08 | -$90.88M 10-Q · filed 2022-11-08 | -$118.94M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$31.38M 10-Q · filed 2022-08-09 | -$58.26M 10-Q · filed 2022-08-09 | -$86.32M derived: sum of 3 quarters · filed 2022-08-09 | -$123.04M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$26.88M 10-Q · filed 2022-05-10 | -$54.95M derived: sum of 2 quarters · filed 2022-05-10 | -$91.67M derived: sum of 3 quarters · filed 2022-05-10 | -$120.52M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$28.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$64.78M derived: sum of 2 quarters · filed 2022-03-17 | -$93.64M derived: sum of 3 quarters · filed 2022-03-17 | -$120.23M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | -$36.72M 10-Q · filed 2021-11-04 | -$65.58M derived: sum of 2 quarters · filed 2021-11-04 | -$92.16M 10-Q · filed 2021-11-04 | -$115.60M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$28.86M 10-Q · filed 2021-08-05 | -$55.45M 10-Q · filed 2021-08-05 | -$78.88M derived: sum of 3 quarters · filed 2021-08-05 | -$96.94M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$26.59M 10-Q · filed 2021-05-13 | -$50.02M derived: sum of 2 quarters · filed 2021-05-13 | -$68.09M derived: sum of 3 quarters · filed 2021-05-13 | -$84.70M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$23.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$41.50M derived: sum of 2 quarters · filed 2021-03-18 | -$58.11M derived: sum of 3 quarters · filed 2021-03-18 | -$75.81M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | -$18.06M 10-Q · filed 2020-11-05 | -$34.68M derived: sum of 2 quarters · filed 2020-11-05 | -$52.38M 10-Q · filed 2020-11-05 | -$69.05M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$16.61M 10-Q · filed 2020-08-06 | -$34.31M 10-Q · filed 2020-08-06 | -$50.99M derived: sum of 3 quarters · filed 2020-08-06 | -$63.22M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$17.70M 10-Q · filed 2020-05-07 | -$34.38M derived: sum of 2 quarters · filed 2020-05-07 | -$46.61M derived: sum of 3 quarters · filed 2020-05-07 | -$56.16M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$16.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$28.91M derived: sum of 2 quarters · filed 2020-03-16 | -$38.45M derived: sum of 3 quarters · filed 2020-03-16 | -$46.24M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | -$12.23M 10-Q · filed 2019-11-07 | -$21.78M derived: sum of 2 quarters · filed 2019-08-08 | -$29.57M 10-Q · filed 2019-11-07 | -$37.00M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-06-30 | -$9.55M 10-Q · filed 2019-08-08 | -$17.34M 10-Q · filed 2019-08-08 | -$24.77M derived: sum of 3 quarters · filed 2019-08-08 | -$31.14M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$7.79M 10-Q · filed 2019-05-13 | -$15.22M derived: sum of 2 quarters · filed 2019-05-13 | -$21.59M derived: sum of 3 quarters · filed 2019-05-13 | -$24.13M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | -$7.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$13.80M derived: sum of 2 quarters · filed 2019-03-25 | -$16.34M derived: sum of 3 quarters · filed 2019-03-25 | -$18.39M 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | -$6.37M 10-Q · filed 2018-11-13 | -$8.91M derived: sum of 2 quarters · filed 2018-11-13 | -$10.96M 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | -$2.54M 10-Q · filed 2018-08-09 | -$4.59M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |